The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”

The safety notice was issued due to the risk of pieces of the needles dislodging into tissue during procedures. 

The group was recently asked to provide input on a new set of recommendations for image-guided biopsies of suspicious breast lesions—offering providers clarity on key clinical scenarios.

Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease. 

In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.

“There is enormous potential here, and the [American Cancer Society] is thrilled with the outcome of this study," one investigators says. 

Between 20% to 24% of all breast cancers diagnosed during a decade-long period were found in women between the ages of 18 to 49, according to research presented at RSNA 2025. 

During an education session at RSNA 2025, several experts who contributed to the manual spoke on what has changed and how these revisions will affect providers.